You are here: Industry Insights > alliance

News List

Dr Jyotsna Dhawan joins DBT/India Alliance as CEO expresspharma
December 07, 2021
She has taken over responsibilities from Dr Vasan Sambandamurthy with effect from 1st December, 2021 till further communication
Rentschler, Leukocare Extend Service Offering with U.S. Site contractpharma
March 23, 2021
Opens Leukocare’s U.S. development labs and offices at Rentschler's facility in the Greater Boston area, where the two companies will work together.
Boehringer forms alliance with Bridge Biotherapeutics for IPF drug pharmaceutical-technology
July 22, 2019
Boehringer Ingelheim has entered a collaboration and licence agreement to develop South Korea-based Bridge Biotherapeutics’ drug candidate for fibrosing interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF).
Pistoia Alliance, backed by Roche, AZ and Bayer, to Introduce FAIR Project contractpharma
July 17, 2019
Includes a toolkit to help companies implement the FAIR guiding principles.
Cancer Research UK forms alliance for oncology medicines pharmaceutical-technology
July 03, 2019
Cancer Research UK has collaborated with life sciences venture capital firm SV Health Investors (SV) to support the development of cancer drugs.
Evotec, Celgene Expand Strategic Alliance contractpharma
June 10, 2019
Expanded neurodegenerative alliance to include a new cell type, triggering $9.0 million payment to Evotec.
AstraZeneca forms drug discovery alliance with BenevolentAI pharmaceutical-technology
May 05, 2019
AstraZeneca has partnered with artificial intelligence (AI) company BenevolentAI to develop treatments for chronic kidney disease and idiopathic pulmonary fibrosis.
Eisai and UCL deepen drug discovery alliance pharmaceutical-technology
December 10, 2018
Japanese pharmaceutical company Eisai has expanded its drug discovery collaboration with University College London (UCL) in the UK for additional five years to 2023......
New UK Health Data Research Alliance to boost medical research pharmatimes
December 06, 2018
The UK’s leading academics and health data specialists are being brought together under a new alliance that aims to develop new ways to design and support the medical research of the future, to ultimately improve the care patients receive from the NHS.
PharmaMar signs commercialisation and distribution agreement for Aplidin® pharmaasia
January 05, 2018
PharmaMar has announced a commercialisation and distribution license agreement with Megapharm Ltd. for the marine-derived anticancer drug Aplidin® (plitidepsin) in Israel and the territory known as the Palestinian Authority.

Previous page 1 2 Next page